225 related articles for article (PubMed ID: 30291826)
1. Durable remission of a patient with primary cutaneous CD8
Al Aoun SM; Iqbal S; AlHalouli TM; Zaidi SZ; Motabi IH
Hematol Oncol Stem Cell Ther; 2021 Mar; 14(1):71-75. PubMed ID: 30291826
[TBL] [Abstract][Full Text] [Related]
2. R-hyper-CVAD versus R-CHOP/cytarabine with high-dose therapy and autologous haematopoietic stem cell support in fit patients with mantle cell lymphoma: 20 years of single-center experience.
Widmer F; Balabanov S; Soldini D; Samaras P; Gerber B; Manz MG; Goede JS
Ann Hematol; 2018 Feb; 97(2):277-287. PubMed ID: 29147847
[TBL] [Abstract][Full Text] [Related]
3. Complete remission in two cases of adult T-cell leukemia/lymphoma treated with hyper-CVAD: a case report and review of the literature.
Alduaij A; Butera JN; Treaba D; Castillo J
Clin Lymphoma Myeloma Leuk; 2010 Dec; 10(6):480-3. PubMed ID: 21156467
[TBL] [Abstract][Full Text] [Related]
4. [Primary cutaneous aggressive epidermotropic cytotoxic CD8 positive T cell lymphoma: report of one case].
Intriago B M; Peña O C; Gray H AM; Cabrera C ME; Martínez C V
Rev Med Chil; 2012 Mar; 140(3):368-72. PubMed ID: 22689119
[TBL] [Abstract][Full Text] [Related]
5. Primary cutaneous aggressive epidermotropic CD8+ T-cell lymphoma: report of two cases with no evidence of systemic disease.
Szepesi Á; Csomor J; Rajnai H; Erős N; Wikonkál N; Kárpáti S; Matolcsy A; Marschalkó M
Eur J Dermatol; 2012; 22(5):690-1. PubMed ID: 22940730
[No Abstract] [Full Text] [Related]
6. Central nervous system relapse of primary cutaneous CD8
Oun H; Wilson M; Leach M; McKay P
Br J Haematol; 2021 Apr; 193(1):9. PubMed ID: 33336793
[No Abstract] [Full Text] [Related]
7. Primary cutaneous aggressive epidermotropic CD8+ T cell lymphoma: a diagnostic and therapeutic challenge.
Nofal A; Abdel-Mawla MY; Assaf M; Salah E; Abd-Elazim H
Int J Dermatol; 2014 Jan; 53(1):76-81. PubMed ID: 23786415
[No Abstract] [Full Text] [Related]
8. Ten-year follow-up after intense chemoimmunotherapy with Rituximab-HyperCVAD alternating with Rituximab-high dose methotrexate/cytarabine (R-MA) and without stem cell transplantation in patients with untreated aggressive mantle cell lymphoma.
Romaguera JE; Fayad LE; Feng L; Hartig K; Weaver P; Rodriguez MA; Hagemeister FB; Pro B; McLaughlin P; Younes A; Samaniego F; Goy A; Cabanillas F; Kantarjian H; Kwak L; Wang M
Br J Haematol; 2010 Jul; 150(2):200-8. PubMed ID: 20528872
[TBL] [Abstract][Full Text] [Related]
9. [Aggressive T cytotoxic CD8+ epidermotropic cutaneous lymphoma: a case in a patient with Steinert's myotonic dystrophy].
Du-Thanh A; Durand L; Costes V; Guillot B; Dereure O
Ann Dermatol Venereol; 2006 Dec; 133(12):991-4. PubMed ID: 17185931
[TBL] [Abstract][Full Text] [Related]
10. Complete remission in advanced blastic NK-cell lymphoma/leukemia in elderly patients using the hyper-CVAD regimen.
Shapiro M; Wasik MA; Junkins-Hopkins JM; Rook AH; Vittorio CC; Itakura H; Frankel MC; Georgala S; Schuster SJ
Am J Hematol; 2003 Sep; 74(1):46-51. PubMed ID: 12949889
[TBL] [Abstract][Full Text] [Related]
11. Treatment with hyperfractionated cyclophosphamide, vincristine, doxorubicin, and dexamethasone combined with cytarabine and methotrexate results in poor mobilization of peripheral blood stem cells in patients with mantle cell lymphoma.
Hill BT; Rybicki L; Smith S; Dean R; Kalaycio M; Pohlman B; Sweetenham J; Tench S; Sobecks R; Andresen S; Copelan E; Bolwell BJ
Leuk Lymphoma; 2011 Jun; 52(6):986-93. PubMed ID: 21314484
[TBL] [Abstract][Full Text] [Related]
12. Primary Cutaneous Aggressive Epidermotropic CD8+ T-cell Lymphoma with Brain Involvement and Mimicking Dermatomyositis.
Terui H; Yamasaki K; Yoshida S; Aiba S
Acta Derm Venereol; 2018 Jan; 98(1):128-129. PubMed ID: 28597026
[No Abstract] [Full Text] [Related]
13. Untreated aggressive mantle cell lymphoma: results with intensive chemotherapy without stem cell transplant in elderly patients.
Romaguera JE; Khouri IF; Kantarjian HM; Hagemeister FB; Rodriguez MA; McLaughlin P; Sarris AH; Younes A; Rodriguez J; Cabanillas F
Leuk Lymphoma; 2000 Sep; 39(1-2):77-85. PubMed ID: 10975386
[TBL] [Abstract][Full Text] [Related]
14. Case of blastic plasmacytoid dendritic cell neoplasm.
Aoi J; Ogata A; Makino T; Sakai K; Masuguchi S; Fukushima S; Jinnin M; Inoue Y; Ihn H
J Dermatol; 2012 Dec; 39(12):1066-7. PubMed ID: 22970734
[No Abstract] [Full Text] [Related]
15. [Facial ulcerated nodules revealing primary cutaneous CD8-positive aggressive epidermotropic cytotoxic T-cell lymphoma].
Rolland M; Dinulescu M; Saillard C; Battistella M; Le Gall F; Lhomme F; Gangneux JP; Dupuy A; Adamski H
Ann Dermatol Venereol; 2020 Nov; 147(11):764-768. PubMed ID: 32527516
[TBL] [Abstract][Full Text] [Related]
16. High rate of durable remissions after treatment of newly diagnosed aggressive mantle-cell lymphoma with rituximab plus hyper-CVAD alternating with rituximab plus high-dose methotrexate and cytarabine.
Romaguera JE; Fayad L; Rodriguez MA; Broglio KR; Hagemeister FB; Pro B; McLaughlin P; Younes A; Samaniego F; Goy A; Sarris AH; Dang NH; Wang M; Beasley V; Medeiros LJ; Katz RL; Gagneja H; Samuels BI; Smith TL; Cabanillas FF
J Clin Oncol; 2005 Oct; 23(28):7013-23. PubMed ID: 16145068
[TBL] [Abstract][Full Text] [Related]
17. High relapse rate of T cell acute lymphoblastic leukemia in adults treated with Hyper-CVAD chemotherapy in Sweden.
Kozlowski P; Åström M; Ahlberg L; Bernell P; Hulegårdh E; Hägglund H; Karlsson K; Markuszewska-Kuczymska A; Tomaszewska-Toporska B; Smedmyr B; Amini RM; Hallböök H;
Eur J Haematol; 2014; 92(5):377-81. PubMed ID: 24443846
[TBL] [Abstract][Full Text] [Related]
18. Post-transplant hepatosplenic T-cell lymphoma successfully treated with HyperCVAD regimen.
Tey SK; Marlton PV; Hawley CM; Norris D; Gill DS
Am J Hematol; 2008 Apr; 83(4):330-3. PubMed ID: 17876769
[TBL] [Abstract][Full Text] [Related]
19. High-dose chemotherapy followed by autologous bone marrow transplantation versus dexamethasone, cisplatin, and cytarabine in aggressive non-Hodgkin's lymphoma with partial response to front-line chemotherapy: a prospective randomized italian multicenter study.
Martelli M; Vignetti M; Zinzani PL; Gherlinzoni F; Meloni G; Fiacchini M; De Sanctis V; Papa G; Martelli MF; Calabresi F; Tura S; Mandelli F
J Clin Oncol; 1996 Feb; 14(2):534-42. PubMed ID: 8636768
[TBL] [Abstract][Full Text] [Related]
20. Outcome of treatment of adult acute lymphoblastic leukemia with hyperfractionated cyclophosphamide, doxorubicin, vincristine, dexamethasone/methotrexate, cytarabine: results from an Australian population.
Morris K; Weston H; Mollee P; Marlton P; Gill D; Kennedy G
Leuk Lymphoma; 2011 Jan; 52(1):85-91. PubMed ID: 21133717
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
